Stockscreener 앱 받기
1.05
0.00%
0.00
시간 외 거래:
1.05
전일 마감가:
$1.05
열려 있는:
$1.05
하루 거래량:
17,508
Relative Volume:
0.29
시가총액:
$9.15M
수익:
$6.74M
순이익/손실:
$-14.74M
주가수익비율:
-0.4669
EPS:
-2.2491
순현금흐름:
$-18.31M
1주 성능:
-5.41%
1개월 성능:
+0.48%
6개월 성능:
-16.00%
1년 성능:
-34.78%
1일 변동 폭
$1.04
$1.0838
1주일 범위
$1.02
$1.1155
52주 변동 폭
$0.93
$2.42
Evogene Ltd Stock (EVGN) Company Profile
EVGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.05 | 9.15M | 6.74M | -14.74M | -18.31M | -2.2491 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-08 | 개시 | ROTH Capital | Buy |
| 2021-07-29 | 개시 | Aegis Capital | Buy |
| 2020-12-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2013-12-16 | 개시 | Oppenheimer | Outperform |
Evogene Ltd 주식(EVGN)의 최신 뉴스
Evogene Announces CFO Resignation and Finance Leadership Transition - TipRanks
Evogene announces CFO resignation and interim appointment By Investing.com - Investing.com Australia
Evogene announces CFO resignation and interim appointment - Investing.com
Evogene (NASDAQ: EVGN) plans CFO change as VP Finance steps up to new role - Stock Titan
Evogene Ltd. Announces CFO Changes - marketscreener.com
Breakout Watch: Is Evogene Ltd stock heavily shortedJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - baoquankhu1.vn
US Market Wrap: How Evogene Ltd stock performs in weak economyNew Guidance & Expert Verified Stock Movement Alerts - Bộ Nội Vụ
Published on: 2026-01-11 04:12:19 - Улправда
Portfolio Shifts: Can Evogene Ltd stock sustain market leadershipDividend Hike & Low Risk Entry Point Guides - moha.gov.vn
HOKA Model Insights: Will Evogene Ltd. stock benefit from upcoming earnings reportsTrail vs Road Selection & updated model highlights and notes - Улправда
Is Evogene Ltd. stock undervalued vs historical averages2025 Buyback Activity & Weekly Watchlist for Hot Stocks - Улправда
Why Evogene Ltd. stock appeals to dividend seekers2025 EndofYear Setup & Real-Time Volume Spike Alerts - Улправда
Is Evogene Ltd. stock attractive for growth ETFsQuarterly Earnings Summary & Daily Entry Point Trade Alerts - Улправда
Will Evogene Ltd. stock remain a Wall Street favoriteJuly 2025 Reactions & Weekly High Return Opportunities - Улправда
Is Evogene Ltd. stock attractive for hedge fundsWeekly Trade Summary & AI Driven Price Predictions - Улправда
Evogene, Unravel Biosciences announce scientific collaboration - TipRanks
How Evogene Ltd. stock compares to industry benchmarksInterest Rate Changes & Affordable Portfolio Growth - ulpravda.ru
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders - Finviz
Evogene (NASDAQ:EVGN) Stock Passes Below Fifty Day Moving Average – Time to Sell? - Defense World
Panic Selling: Will Evogene Ltd stock remain a Wall Street favorite2025 Price Targets & Low Drawdown Trading Strategies - moha.gov.vn
Evogene Appoints Dr. Olga Nissan as Vice President of Business Development to Drive AI-Driven Growth - The Globe and Mail
Evogene appoints Dr. Olga Nissan as VP of business development By Investing.com - Investing.com Nigeria
Evogene appoints Nissan as VP of Business Development - TipRanks
Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development - Finviz
Evogene appoints Dr. Olga Nissan as VP of business development - Investing.com
Is Evogene Ltd. stock resilient to inflationJuly 2025 Setups & Free Daily Entry Point Trade Alerts - Улправда
Will Evogene Ltd. stock benefit from upcoming earnings reportsJuly 2025 Drop Watch & AI Based Trade Execution Alerts - DonanımHaber
Can Evogene Ltd. stock sustain market leadershipWeekly Gains Report & Safe Capital Investment Plans - DonanımHaber
Can Evogene Ltd. stock sustain free cash flow growth2025 Price Momentum & Entry and Exit Point Strategies - DonanımHaber
Should I hold or sell Evogene Ltd. stock in 20252025 Volume Leaders & Technical Buy Zone Confirmation - Улправда
Will Evogene Ltd. stock keep outperforming rivalsWeekly Stock Recap & Growth Focused Investment Plans - Улправда
Reviewing Vera Therapeutics (NASDAQ:VERA) & Evogene (NASDAQ:EVGN) - Defense World
Will Introduced Innovation Sustain VLS Finance Limiteds GrowthInterest Rate Changes & Superior Trading Strategies - earlytimes.in
Investment Recap: Is Evogene Ltd stock a smart buy before Fed meetingTrade Entry Report & Free Growth Oriented Trading Recommendations - BỘ NỘI VỤ
Evogene (NASDAQ:EVGN) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World
How AI Is Breaking Down the Bottlenecks in Small Molecule Drug Discovery - Unite.AI
Evogene (EVGN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Sahm
Evogene (NASDAQ:EVGN) Share Price Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL (PR Newswire) - Aktiellt
Evogene shares climb 5% as cost reductions help deliver earnings beat - MSN
Evogene Ltd. Reports Strategic Shift and Financial Results - MSN
Evogene Ltd. Earnings Call: Strategic Shifts and Optimism - The Globe and Mail
Is Evogene Ltd. stock cheap compared to fundamentals - newser.com
Evogene Ltd. (NASDAQ:EVGN) Q3 2025 Earnings Call Transcript - Insider Monkey
Can Evogene Ltd. stock hit record highs again2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
Evogene Ltd (EVGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):